Idiopathic Interstitial Pneumonias: A Review of the Past and Emerging Therapies.

Lisa M Sagardia, Bethany E Taylor, Ishan Mehta

Journal of pharmacy practice 2023 Jun

filter terms:

PurposeThis article is an in-depth review of the complex classification, diagnosis, and treatment of idiopathic interstitial pneumonias (IIP), as well as emergence of new treatment options. Summary: Idiopathic interstitial pneumonias consist of various subgroup classifications that require expert analysis of imaging and histology to accurately diagnose this broad group of patients. Timely and accurate assessment of these patients is key in developing an appropriate pharmacological plan. The pathophysiology of IIP is not well understood but has been linked to an immune response resulting in inflammation, fibrosis, or proliferation of lung tissue which reduces lung function. Lung transplantation is currently the only curative option for treatment, but many new antiproliferative and immunosuppressive agents are being used to effectively slow the progression of lung dysfunction. Conclusion: An often mixed radiological and histological pattern along with the invasive nature of biopsy for gold standard diagnosis create a challenge for the accurate identification of IIP. Further understanding of these idiopathic interstitial pneumonias will pave the way forward to the emergence of new treatment options and updates to standards of care.

Citation

Lisa M Sagardia, Bethany E Taylor, Ishan Mehta. Idiopathic Interstitial Pneumonias: A Review of the Past and Emerging Therapies. Journal of pharmacy practice. 2023 Jun;36(3):640-649